No abstract

No abstract

Date palm pollen-DPP (Phoenix dactylifera L) plays an important role in traditional treatment in Iraq, especially for the treatment of fertility or as supplements, flavonoids were important components for date palm pollen, no information is available in the literature about the types of flavonoids in an Iraqi DPP variety El-Ghannmi Ahmar. The HPLC analysis revealed that in an Iraqi DPP variety El-Ghannmi Ahmar contains many types of flavonoids (13.590 µg/g lincoceric acid, 122.251 µg/ gIsorhamnetin,71.146 µg/g chlorogenic acid, 99.188 µg/g ferulic acid, 64.574 µg/g naringin, 109.117 µg/g apigenin, 48.391 µg/g apigenin-7-O-beta glycopyranoside, 28.883 µg/g letulin and 18.291 µg/g letulin-7-O-beta glycosides).

The human cytomegalovirus (CMV) is one of the common viral infections worldwide that represent a major cause of congenital infections. To determine the seroprevalence of CMV in women with bad obstetric history and sociodemographic characteristics that may influence the seropositivity, a case control descriptive prospective study was conducted in Kirkuk, Iraq. A 838 women with age range from 14 to 48 were included in the study. Of the total, 547 women were with bad obstetric history (BOH) and 291 women with normal previous pregnancy as control group. All the serum samples collected from the study and control groups were tested for CMV IgM and IgG antibodies by ELISA kits. CMV IgM seroprevalence was higher in women with BOH. CMV IgG seroprevalence was with no significant difference between BOH and control. CMV IgG seroprevalence significantly influenced by age, education, smoking, and family size. However, CMV IgM seroprevalence significantly associated with pregnancy, residence, and animal exposure. Odd ratio confirmed the association between CMV IgG and age, crowding index, residence, smoking, and number of abortion in women with BOH. In addition, current CMV infection significantly associated with residence in women with BOH.

The current study included estimation of Aldose reductase (AR) activity in serum of diabetic  patients. The study included (47) samples of seram from  diabetic patients serum (both types I and II), the patients age ranged from (9-80) years old, and (36) samples of seram from healthy people (control group) aged between (12-80) years old. The results showed significant elevation (P <0.05) in the AR activity in diabetic patients for both types compared with control group. The AR activity was (38.65 ±9.60) IU/ L in the serum of type II diabetes patients and (29.52 ± 5.75) IU/ L in patients with type I diabetes, compared to (11.01 ± 2.19) IU/ L in the serum of healthy people